WhatFinger


New Israeli approach stops lung cancer cells from developing resistance to chemotherapy in mice.

Triple treatment could keep lung cancer from coming back



Lung cancer patients know that the statistics for a full recovery are not in their favor, but new research coming out of Israel could alter these grim figures. According to the Weizmann Institute of Science’s Prof. Yosef Yarden, an innovative strategy involving a three-pronged approach might keep an aggressive form of lung cancer at bay.

Support Canada Free Press


Yarden and his lab staff showed on mouse models that their approach stops lung cancer cells from developing resistance to chemotherapy. Lung cancer is by far the leading cause of cancer death worldwide (for men and women) and is responsible for some 1.59 million deaths a year, according to the World Health Organization. While cancer recurrence is always a worry for anyone who has finished treatment of the disease, studies have shown that if lung cancer returns there is almost no chance of the tumor ever being cured, according to the American Cancer Society. Add to that the knowledge that the recurring cancer is often resistant to the chemotherapy and other drugs that originally drove it into remission. More...


View Comments

Guest Column Israel21c -- Bio and Archives

Items of notes and interest from the web.


Sponsored